Uncommon long-term survival in a patient with chronic myeloid leukemia-Reference-Cited by-同舟云学术

Uncommon long-term survival in a patient with chronic myeloid leukemia

Published:2009-01 Issue:8 Volume:48 Page:1215-1216
ISSN:0284-186X
Container-title:Acta Oncologica
language:en
Short-container-title:Acta Oncologica

Author:

Stagno Fabio,Vigneri Paolo,Stagno Fabio,Vigneri Paolo,Del Fabro Vittorio,Stella Stefania,Berretta Salvatore,Massimino Michele,Tirrò Elena,Messina Angelo,Di Raimondo Francesco

Publisher

Informa UK Limited

Subject

Radiology, Nuclear Medicine and imaging,Oncology,Hematology,General Medicine

Link

http://www.tandfonline.com/doi/pdf/10.3109/02841860903156475

Reference7 articles.

1. Applying the discovery of the Philadelphia chromosome

2. Five-Year Follow-up of Patients Receiving Imatinib for Chronic Myeloid Leukemia

3. Randomized comparison of interferon α and hydroxyurea with hydroxyurea monotherapy in chronic myeloid leukemia (CML-study II): prolongation of survival by the combination of interferon α and hydroxyurea

4. Chronic myelogenous leukemia: recent advances

5. The Biology of Chronic Myeloid Leukemia

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting BCL-2 as a Therapeutic Strategy for Primary p210BCR-ABL1-positive B-ALL Cells;In Vivo;2020

2. Efficacy of Nilotinib in a CML Patient Expressing the Three-way Complex Variant Translocation t(2;9;22);Anticancer Research;2019-07

3. Colony-Forming Cell Assay Detecting the Co-Expression of JAK2V617F and BCR-ABL1 in the Same Clone: A Case Report;Acta Haematologica;2019

4. Successful Management of a Pregnant Patient With Chronic Myeloid Leukemia Receiving Standard Dose Imatinib;In Vivo;2019

5. A case report of a 33-year chronic phase survivor of chronic myeloid leukemia;Medical Oncology;2011-02-27